Last10K.com

Zeta Acquisition Corp Ii (ARPO) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2013

SEC Filings

ARPO Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ARPO Annual Reports

ARPO Quarterly Reports

ARPO Corporate News

Aerpio Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1422142 Ticker: ARPO
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2013
Mar. 31, 2014
Document and Entity Information [Abstract]    
Entity Registrant Name ZETA ACQUISITION CORP II  
Entity Central Index Key 0001422142  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-K  
Document Period End Date Dec. 31, 2013  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus FY  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   5,000,000
Entity Public Float $ 0  

View differences made from one year to another to evaluate Aerpio Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aerpio Pharmaceuticals, Inc..

Continue

Assess how Aerpio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aerpio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aerpio Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Exhibit 32.2: Certification
Ticker: ARPO
CIK: 1422142
Form Type: 10-K Annual Report
Accession Number: 0001213900-14-001894
Submitted to the SEC: Mon Mar 31 2014 11:23:05 AM EST
Accepted by the SEC: Mon Mar 31 2014
Period: Tuesday, December 31, 2013
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/arpo/0001213900-14-001894.htm